Your trusted source for investing success
Trump’s policies are affecting gold. You should know what’s going on. Click here to get our FREE report.
Click here to get your free report!Discover what the experts see coming in the Age of Trump with our INN Insider's Report free of charge! Includes expert insights into Trump and his effect on mining and gold.
22nd Century Group announced in cooperation with the University of Virginia it had completed a harvest of hemp plants and potentially found hemp varieties for commercial production.
By Pia Rivera
Gensource Potash Corporation (“Gensource” or the “Company”) (TSXV:GSP) is pleased to provide an update related to the ongoing efforts to expand upon the resource confirmation work completed to-date at its 100% owned Vanguard property in central Saskatchewan.
Vitality Biopharma announced additional preclinical efficacy results for the treatment of colitis.
By Pia Rivera
3D Signatures Inc. (TSX-V:DXD) (OTCQB:TDSGF) (FSE:3D0) (the “Company” or “3DS”) is pleased to announce the addition of Keith Cassidy to the Company’s board of directors and to the Company’s audit committee, effective immediately.
Tetra Bio-Pharma signed an agreement deal with Aphria to start promoting a co-developed medical cannabis blend product.
Biotechnology has fully cemented itself as a distinct side of the life science market, often offering companies the availability to work in pharmaceutical more general health products.
ProMIS Neurosciences provided an update from a preclinical study comparing PMN310 to other amyloid beta-directed antibodies combating Alzheimer’s disease.
With a few months left to go in 2017, here the Investing News Network (INN) looks at the 4 top pharma stocks on the NASDAQ year-to-date.
By Jocelyn Aspa
Infinity Pharmaceuticals, Sorrento Therapeutics, CASI Pharmaceuticals, KalVista Pharmaceuticals, and Prima BioMed topped last week’s NASDAQ biotech stock list.
By Jocelyn Aspa
Imagin Medical (CSE:IME) has announced that further to its press releases of September 26 and October 4, it is closing the second and final tranche of its non-brokered private placement for gross proceeds of $357,060.
As quoted in the press release:
Due to over-subscription, the Company will be closing on a total
By Melissa Shaw
Nickel prices have been inconsistent in 2017, but some nickel companies have seen share price gains. Here are the five top nickel stocks so far this year.
By Jocelyn Aspa
InspireMD (NYSE:NSPR) has announced it has signed an agreement with CorpMedical Chile Ltda to distribute the MGuard Prime Embolic Protection System for the treatment of acute coronary syndromes.
As quoted in the press release:
Mr. Jaime Kehr, Chief Executive Officer of CorpMedical Chile Ltda, noted, “MGuard Prime™ with its MicroNet™ technology is
By Shelly Kumar
CFN Media Group (“CannabisFN”), the leading creative agency and media network dedicated to legal cannabis, announces publication of an article covering Harvest One Cannabis Inc.(TSXV:HVST) tremendous progress in growing its international footprint. The company’s wholly-owned United Greeneries subsidiary is awaiting approval from Health Canada for its ACMPR license to sell, but its
By Shelly Kumar
SeeThruEquity, a leading New York City based independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced that it has issued an update note on DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI).
The note is available here: DMPI October 2017 Update.
DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI)) is a clinical-stage biotechnology firm
By Pia Rivera
3D Signatures Inc. (TSXV:DXD) (OTCQB:TDSGF) (FSE:3D0) (the “Company” or “3DS”), is pleased to announce that, on September 30, 2017, the Company completed the clinical trial component (the “Clinical Trial”), or Stage 3, of its Hodgkin’s lymphoma (“HL”) test (“Telo-HLTM”) validation program.
The world’s pharmaceutical industry is dominated by the American and European markets. According to Forbes top companies of 2017, the 10 biggest drug companies are all located in these two regions.
At the halfway mark of 2017, here’s a look at how these four gene therapy companies are performing so far this year.
By Shelly Kumar
dynaCERT Inc. (TSXV:DYA; OTC:DYFSF) (“dynaCERT” or the “Company”) is pleased to announce that it has successfully filed a Provisional Patent Application in the United States for the following patent: “Systems and Methods for Tracking Greenhouse Gas Emissions Associated With an Entity”.
Our system incorporates dynaCERT’s proprietary technology which has been developed after years of extensive
By Micha Boon
3D Signatures Inc. (TSXV:DXD) (OTCQB:TDSGF) (FSE:3D0) (the “Company” or “3DS”) is pleased to announce the close of its non-brokered private placement (the “Private Placement”) of 2,000,000 common shares (the “Shares”) at a price of C $0.25 per Share for gross proceeds of C $500,000 with ScreenCell SA (“ScreenCell”), announced October
By Shelly Kumar
Harvest One Cannabis Inc.(TSXV:HVST) is pleased to provide a market update on its wholly owned subsidiary, Satipharm AG (“Satipharm”):
Satipharm has received German “Free Sales Certificate” reducing constraints for international export
Australian Regulatory Authority has issued final approval for CBD capsule prescription in Australia
Strong increase in European dietary supplement
Trump’s policies are affecting gold. You should know what’s going on. Click here to get our FREE report.
Click here to get your free report!Discover what the experts see coming in the Age of Trump with our INN Insider's Report free of charge! Includes expert insights into Trump and his effect on mining and gold.
